Form4insider filings, from the source

Company · CIK 0001326110 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

ImmunityBio, Inc. · IBRX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $3.6M · 3net −$3.6M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJun 28Jul 13Jul 28Aug 13Aug 28Sep 13Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jul 2, 2026 SForm 4 →Jul 6, 8:26 pm EDTCheryl CohenDirector131,210$9.50$1,246,941125,386−51.1%10b5-1
Jul 2, 2026 MForm 4 →Jul 6, 8:26 pm EDTCheryl CohenDirector55,979$2.98$166,817256,596—10b5-1
Jul 1, 2026 SForm 4 →Jul 6, 8:25 pm EDTChristobel SeleckyDirector159,478$9.02$1,439,0660−100%10b5-1
Jul 1, 2026 MForm 4 →Jul 6, 8:25 pm EDTChristobel SeleckyDirector159,478$2.99$476,489159,478—10b5-1
Jun 29, 2026 SForm 4 →Jul 1, 5:04 pm EDTChristobel SeleckyDirector96,722$9.01$871,2160−100%10b5-1
Jun 29, 2026 MForm 4 →Jul 1, 5:04 pm EDTChristobel SeleckyDirector96,722$2.94$284,3701,000—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jul 2, 2026 MForm 4 →Jul 6, 8:26 pm EDTCheryl CohenDirector55,979——111,958—10b5-1
Jul 1, 2026 MForm 4 →Jul 6, 8:25 pm EDTChristobel SeleckyDirector159,478——0—10b5-1
Jun 29, 2026 MForm 4 →Jul 1, 5:04 pm EDTChristobel SeleckyDirector96,722——124,414—10b5-1